Literature DB >> 4076342

The actions of felodipine on arrhythmias and other responses to myocardial ischaemia in conscious rats.

M J Curtis, K M Johnston, B A Macleod, M J Walker.   

Abstract

The antiarrhythmic activity of felodipine was investigated in conscious chronically prepared rats subjected to coronary artery occlusion. By deliberate high or low placement of an occluder, either large or small occluded zones were produced. In rats with small occluded zones (SOZ), felodipine i.v. (0.2 mumol/kg slow injection + 0.01 mumol/kg per min infusion, and 12.2 mumol/kg slow injection) possessed slight antiarrhythmic activity. In rats with large occluded zones (LOZ), similar doses of felodipine had little antiarrhythmic activity. Felodipine produced a dose-dependent reduction in blood-pressure and delayed the development of ECG signs of ischaemia (ST elevation). The occluded zone size was not reduced by felodipine, although some myocardial salvage (8-17%) may have occurred in SOZ rats. It is concluded that felodipine, at doses producing severe hypotension associated with vasodilatation, possesses little antiarrhythmic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076342     DOI: 10.1016/0014-2999(85)90601-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

2.  The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.

Authors:  B A MacLeod; M Moult; K M Saint; M J Walker
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 3.  Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat.

Authors:  M J Curtis; M J Walker
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

5.  The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.

Authors:  M J Curtis; M J Walker
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.